Related Experiment Video
Updated: Jan 29, 2026
16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
13.2K
Acute Respiratory Failure in Renal Transplant Recipients: A Single Center Experience
H Eylül Bozkurt Yılmaz1, Elif Küpeli, Nazan Şen
1From the Pulmonary Medicine, Baskent University, Adana, Turkey.
Summary
Acute respiratory failure is common in renal transplant recipients, with bacterial pneumonia and cardiogenic pulmonary edema being leading causes. Early intensive care unit admission and infection prophylaxis may improve outcomes for these high-risk patients.
Area of Science:
- Nephrology
- Critical Care Medicine
- Infectious Diseases
Background:
- Renal transplant recipients face increased risks of critical illnesses, including acute respiratory failure.
- Understanding the specific causes and outcomes of acute respiratory failure in this population is crucial for improving patient care.
Purpose of the Study:
- To determine the frequency and primary causes of acute respiratory failure in patients who have received a renal transplant.
- To analyze the outcomes, including mortality and graft function, associated with acute respiratory failure in this cohort.
Main Methods:
- A retrospective observational study was conducted on renal transplant recipients admitted to the ICU for acute respiratory failure between 2011 and 2017.
- Acute respiratory failure was defined by specific oxygen saturation levels or the need for mechanical ventilation.
Main Results:
- Out of 187 renal transplant recipients, 11 (31.4%) experienced acute respiratory failure requiring ICU admission.
- Pneumonia (particularly bacterial) and cardiogenic pulmonary edema were the most frequent causes, accounting for the majority of cases.
- Mortality was high (54.5%), with pneumonia, cardiogenic pulmonary edema, and cerebrovascular thromboembolism as primary causes of death.
Conclusions:
- Acute respiratory failure presents a significant mortality and morbidity risk for renal transplant recipients.
- Bacterial pneumonia and cardiogenic pulmonary edema are identified as the main drivers of acute respiratory failure in this population.
- Strategies such as enhanced chemoprophylaxis and timely ICU admission may enhance survival rates and outcomes.
Related Concept Videos
01:21Acute Respiratory Failure-I
977
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
977
01:21Acute Respiratory Failure-II
1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
01:29Acute Respiratory Failure-V
493
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
493
01:30Acute Respiratory Failure-III
869
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
869
01:23Acute Respiratory Failure-IV
555
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
555
01:11Renal Failure: Dose Adjustments
463
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
463